CELINA MACADANGDANG: Open Payments
NPI 1194287664 · KAPOLEI, HI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$565 in 24 payments from 13 companies in 2025. Trend: 2023 $44 · 2024 $62 · 2025 $565
Food & beverage: $565
| Company | Payments | Amount |
|---|---|---|
| PFIZER INC. | 3 | $77 |
| ABBVIE INC. | 2 | $65 |
| Novo Nordisk Inc | 3 | $59 |
| Bayer Healthcare Pharmaceuticals Inc. | 3 | $58 |
| Gilead Sciences, Inc. | 2 | $54 |
| Exact Sciences Corporation | 2 | $51 |
| Merck Sharp & Dohme LLC | 2 | $48 |
| Amgen Inc. | 2 | $46 |
| Dexcom, Inc. | 1 | $27 |
| ViiV Healthcare Company | 1 | $26 |
Products named: PREVNAR 20, UBRELVY, Kerendia, KRYSTEXXA, Wegovy, Cologuard Collection Kit, Dexcom G6 Transmitter, APRETUDE.
Industry payments across HI — which companies pay providers there.
